FAP-based targeted radionuclides as immune modulators in ovarian and breast cancer

Reverso

1 month ago

Onsite

Contract

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

This project involves exploring targeted radionuclide therapy as a treatment for ovarian cancer and triple-negative breast cancer, focusing on disrupting the tumor microenvironment and enhancing immune response. It integrates radiopharmaceutical science, immunotherapy, and translational oncology to develop combination therapies with potential for clinical application.

Skills

About Reverso

reverso.net

Reverso is a language-technology company that provides online translation and contextual language tools. Its products combine neural machine translation with bilingual examples from real-world corpora (Reverso Context), plus dictionaries, conjugation, pronunciation, and grammar/spell checking. Reverso offers web, mobile apps, browser extensions and APIs to help individuals, learners and professionals produce more accurate, natural multilingual text. The platform is commonly used for translation, localization support and language learning.